SPSB2-iNOS inhibitory cyclic peptide-2
Selected Variant
HY-P10384
Size: 1 Each
SPSB2-iNOS inhibitory cyclic peptide-2 (Compound CP2) is an inhibitor for the interaction of SPRY domain and SOCS-box protein 2 (SPSB2) and iNOS, through binding SPSB2 on iNOS site with KD of 21 nM. SPSB2-iNOS inhibitory cyclic peptide-2 is reduction-resistant and oxidatively stable[1].
Product Specifications
CAS Number
1989528-33-7
UNSPSC
12352209
Target
NO Synthase
Type
Peptides
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/spsb2-inos-inhibitory-cyclic-peptide-2.html
Solubility
10 mM in DMSO
Smiles
O=C(N[C@H](C(N[C@@](C(N[C@H](C(N[C@H](C(N[C@H](C(NCCC(N1)=O)=O)CC(N)=O)=O)CC(N)=O)=O)CC(N)=O)=O)([H])[C@@H](C)CC)=O)CC(O)=O)[C@@H]1CC2=CNC3=CC=CC=C23
Molecular Formula
C36H49N11O12
Molecular Weight
827.84
References & Citations
[1]Yap BK, et al., Redox-stable cyclic peptide inhibitors of the SPSB2-iNOS interaction. FEBS Lett. 2016 Mar;590 (6) :696-704.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Price
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Cytokeratin 19 (Pancreatic Stem Cell Marker) (rKRT19/800), CF740 conjugate, 0.1mg/mL
![B-Raf Mouse Monoclonal Antibody [F1-F4-E10]](https://cdn.genprice.uk/products/992/68dd1c8c061270361ea81c34/imageurl/em1701-32.webp)
Tyrosinase (T311 + OCA1/812), CF740 conjugate, 0.1mg/mL
TLE1 (Synovial Sarcoma Marker) (TLE1/2085), CF405S conjugate, 0.1mg/mL
CD56 / NCAM (NCAM1/795), CF488A conjugate, 0.1mg/mL
